Related references
Note: Only part of the references are listed.Construction, characterization and exemplificative application of bioluminescent Bifidobacterium longum biovar longum
Simone Guglielmetti et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2008)
Heterologous expression of cholesterol oxidase in Bifidobacterium longum under the control of 16S rRNA gene promoter of bifidobacteria
Myeong Soo Park et al.
BIOTECHNOLOGY LETTERS (2008)
Silibinin sensitizes human glioma cells to TRAIL-Mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin
Yong-Gyu Son et al.
CANCER RESEARCH (2007)
A novel binary expression vector for production of human IL-10 in Escherichia coli and Bifidobacterium longum
M. L. Reyes Escogido et al.
BIOTECHNOLOGY LETTERS (2007)
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1
Stavroula Baritaki et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy
Y-F Xu et al.
CANCER GENE THERAPY (2007)
Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells
Taka-Aki Matsui et al.
CARCINOGENESIS (2006)
Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma
C Yi et al.
ACTA PHARMACOLOGICA SINICA (2005)
Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
GF Fu et al.
CANCER GENE THERAPY (2005)
Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival
H Jin et al.
CANCER RESEARCH (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Species identification of genus Bifidobacterium based on partial HSP60 gene sequences and proposal of Bifidobacterium thermacidophilum subsp porcinum subsp nov.
L Zhu et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2003)
Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines
RR Siervo-Sassi et al.
CANCER LETTERS (2003)
Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy:: Selective inhibitor of angiogenesis and hypoxic tumor growth
X Li et al.
CANCER GENE THERAPY (2003)
Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors
T Nakamura et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors
K Yazawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Bifidobacterium longum as a delivery system for cancer gene therapy:: Selective localization and growth in hypoxic tumors
K Yazawa et al.
CANCER GENE THERAPY (2000)
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
SB Gibson et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)